NASEM re­leas­es re­port on med­ical sup­ply-chain re­silien­cy

Sup­ply chains have nev­er had a high­er pro­file than they do right now, but there is no sin­gu­lar “sil­ver bul­let” to blame for the med­ical prod­uct sup­ply chain prob­lem. And while the re­liance on oth­er coun­tries for man­u­fac­tur­ing has had its draw­backs, on-shoring the en­tire sup­ply chain is cost­ly and not fea­si­ble.

That’s the as­sess­ment from the Na­tion­al Acad­e­mies of Sci­ences, En­gi­neer­ing, Med­i­cine, start­ing off its con­sen­sus study re­port on re­silience in the US’s med­ical prod­uct sup­ply chains. Re­leased Thurs­day, the re­port ac­knowl­edges what we al­ready knew: the prod­ucts we take for grant­ed every day are not as easy to ob­tain.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER